). Abosrption, pharmacokinetics, and safety of triclosan after dermal administration. Antimicrobial Agents and Chemotherapy 54 (1): 570-572.
Rea, WJ. (1992). Chemical sensitivity, vol I. Lewis Publishers , Boca Raton.
Reddy L, Bhoola K. (2010). Ochratoxins - food contaminants: impact on human health. Toxins 2 : 771-779.
Rosenman KD. (1979). Cardiovascular disease and environmental exposure. Br J Ind Med 36 : 85-97.
Rufer ES, Hacker TA, Flentke GR, Drake VJ, Brody MJ, Lough J, Smith SM. (2010). Altered
transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. J Nutr 130 : 2765-2771.
Giacco F, Brownlee M. (2010). Oxidative stress and diabetic complications. Circ Res 107 : 1058-1070.
Grotte D, Mattox V, Brubaker R. (1985). Fluorescent, physiological and pharmacokinetic properties of fluorescein. Exp Eye Res 40 : 23-33.
Gupta SK, Halder N, Srivastava S, Trivedi D, Joshi S, Varma SD. (2002). Green tea (Camellia sinensis
advances in the acute promyelocytic leukemia. Int J Hematol 2002; 76 (suppl2): 179-87. http://dx.doi.org/10.1007/BF03165115
77. Shen Z-X, Chen G-Q, Ni J-H, et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997; 89 (9): 3354-60.
78. Au WY, Lie AK, Chim CS, et al. Arsenic trioxide in comparison with chemotherapy and bone marrow transplantation for the treatment of relapsed acute promyelocytic leukemia. Ann Oncol 2003; 14 (5
damage and apoptosis induced by lead. Environ Toxicol Pharmacol 30: 264-271.
Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. (2007). Curcuminphospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 330: 155-163.
Mates JM. (2000). Eff ects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 153 : 83-104.
Mozafari MR, Flanagan J, Matia-Merino L, Awati A, Omri A, Suntres Z, Singh H. (2006). Recent trends in the lipid
Sutharinee Likitnukul, Sarinee Kalandakanond-Thongsong and Sumpun Thammacharoen
JM Halaas JL Leptin and the regulation of body weight in mammals Nature 1998 395 763 70
 Ahren B, Baldwin RM, Havel PJ. Pharmacokinetics of human leptin in mice and rhesus monkeys. Int J Obes Relat Metab Disord. 2000; 24:1579–85. 10.1038/sj.ijo.0801447 11126209
Ahren B Baldwin RM Havel PJ Pharmacokinetics of human leptin in mice and rhesus monkeys Int J Obes Relat Metab Disord 2000 24 1579 85
 Bodosi B, Gardi J, Hajdu I, Szentirmai E, Obal F Jr., Krueger JM. Rhythms of ghrelin, leptin, and sleep in rats: effects of the
, Wachall B, Doroshyenko O, Tomalik-Scharte D, Bastian B, et al. (2010). Absorption, pharmacokinetics, and safety of triclosan after dermal administration. Antimicrobial Agents and Chemotherapy 54 (1): 570-572.
Qiu C, cheng S, Xia Y, Peng B, Tang Q, Tu B. (2011). Eff ects of subchronic benzo(a)pyrene exposure on neurotransmitter receptor gene expression in the rat hippocampus related with spatial learning and memory change. Toxicology 289 (2-3): 83-90.
Ren A, Qiu X, Jin J, Li Z, Ma J, Zhiwen L, et al. (2011). Association of selected
1 Richards M, Williams M, Chalmers E et al. A United Kingdom Haemophilia Centre Doctors’ Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A. Br J Haematology 2010; 149: 498;507.
2 Morfini M. Pharmacokinetics of factor VIII and factor IX. Haemophilia 2003; 9 <Suppl 1=: 94;9..
3 Bjorkman S. Prophylactic dosing of factor VIII and factor IX from a clinical
Renata Rezonja, Lea Knez, Tanja Cufer and Aleš Mrhar
. Pharmacokinetic optimisation of treatment with oral etoposide. Clin Pharmacokinet 2004; 43: 441-6.
13. Montecucco A, Biamonti G. Cellular response to etoposide treatment. Cancer Lett 2007; 252: 9-18.
14. Hande KR. The importance of drug scheduling in cancer chemotherapy: etoposide as an example. Oncologist 1996; 1: 234-9.
15. Greco FA, Johnson DH, Hande KR, Porter LL, Hainsworth JD, Wolff SN. High-dose etoposide (VP-16) in small-cell lung cancer. Semin Oncol 1985; 12(Suppl 2): 42-4.
16. Slevin ML
J. Stasko, J. Stasko, M. Janickova, K. Mikuskova, I. Malachovsky, P. Gengelova, M. Kasaj, M. Smatanova and D. Statelova
The direct oral anticoagulant drugs (DOAC) are generally safe and effective in several clinical settings including acute venous thromboembolic disease, prophylaxis in the postoperative setting, prevention of thromboembolism in patients with non-valvular atrial fibrillation, and in the management of acute coronary syndrome. The relatively short half-life, rapid onset of action, and predictable pharmacokinetics should simplify periprocedural use of the DOAC. The aim of this work is to propose and summarize periprocedural management of patients treated with the DOAC in dental practice and to inform about the principal specifications of this treatment.
Adrian Głogowski, Zbigniew Marczyński, Michał Krzysztof Kołodziejczyk, Jerzy Jambor, Marta Kinga Stefan and Marian Mikołaj Zgoda
Introduction: Dietary supplements are a good way to supplement the deficiency of certain micronutrients and organic components (therapeutic agents) in human body. They are most often available in concentrated form as tablets, capsules, powder or liquid.
Objective: To investigate morphological parameters and the pharmaceutical availability of coated tablets – dietary supplements – that contain selected pharmacopeial titrated dry plant extracts.
Methods: Testing of the effective time of the tablet surface erosion was performed in model acceptor fluids using pharmacopeial methods in static (Erweka apparatus) and dynamic (unlimited diffusion method) conditions. Furthermore, morphological parameters of tablets (the original shape of an ellipse) as well as their hardness were determined.
Results: The effective erosion time was determined by conductometric method using carboxymethylcellulose sodium salt (NaCMC) contained in the tablet. The content of gum arabic and NaCMC in the tablet testifies that the granulate was produced using the “wet granulation” technique which resulted in high hardness of original, esthetic, elliptical tablets and in prolonged disintegration time (erosion).
Conclusions: The used excipients: gum arabic and NaCMC for the production of the tested tablets containing selected dry plant extracts result in their high hardness. The tested dietary supplements are characterized by esthetic design, original shape, and prolonged disintegration time which affects the pharmaceutical availability.